Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216879
Status:
COMPLETED
Last Update Posted:
2015-03-26
First Post:
2005-09-15
Brief Title:
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Study Overview
Official Title:
Long-term Treatment of Scalp Psoriasis With Calcipotriol Plus Betamethasone Dipropionate Gel
Status:
COMPLETED
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the trial is to study the safety and efficacy of long term use of once daily applications as needed of calcipotriol plus betamethasone dipropionate gel as compared to calcipotriol alone in the same gel
The primary response criteria will be the incidence of adverse drug reactions of any type and the incidence of adverse events of concern associated with long-term corticosteroid use on the scalp
The primary response criteria will be the incidence of adverse drug reactions of any type and the incidence of adverse events of concern associated with long-term corticosteroid use on the scalp
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None